Publications
5803 Results
- Journal / Conference
- Journal of Clinical Oncology 26(15S):255s, #5022
- Year
- 2008
- Research Committee(s)
- Genitourinary
- Study Number(s)
- S0219
A sequential treatment approach to muscle-invasive urothelial cancer - a phase II Southwest Oncology Group trial (S0219) of neoadjuvant paclitaxel, carboplatin, and gemcitabine (PCG)
- Journal / Conference
- Journal of Clinical Oncology 26(15S):459s, #8521
- Year
- 2008
- Research Committee(s)
- Myeloma
- Study Number(s)
- S0232
A randomized Southwest Oncology Group study comparing dexamethasone (D) to lenalidomide + dexamethasone (LD) as treatment of newly-diagnosed multiple myeloma (NDMM): impact of cytogenetic abnormalities on efficacy of LD, and updated overall study results
- Journal / Conference
- Journal of Clinical Oncology 26(15S):222s, #4536
- Year
- 2008
- Research Committee(s)
- Gastrointestinal
- Study Number(s)
- S0415
Cetuximab as second-line therapy in patients with metastatic esophageal cancer: a phase II Southwest Oncology Group study
- Journal / Conference
- Journal of Clinical Oncology 26(15S):561s, #10532 (poster)
- Year
- 2008
- Research Committee(s)
- Sarcoma
- Study Number(s)
- S0505
Phase II intergroup study of sorafenib (s) in advanced soft tissue sarcomas (STS) SWOG 0505
- Journal / Conference
- Journal of Clinical Oncology 26(15S):484s, #9007
- Year
- 2008
- Research Committee(s)
- Melanoma
- Study Number(s)
- S0508
Phase II trial of combination thalidomide (thal) plus temozolomide (TMZ), (TT), in patients with metastatic malignant melanoma (MMM): Southwest Oncology Group S0508
- Journal / Conference
- Proceedings of the American Society of Clinical Oncology 2008 Genitourinary Cancers Symposium, abst. 165
- Year
- 2008
- Research Committee(s)
- Genitourinary
- Study Number(s)
- SWOG-9346, S9916
Prostate specific antigen progression (PSA-P) as a predictor of overall survival (OS) in patients (pts) with metastatic prostate cancer (PC): data from S9346 and S9916
- Journal / Conference
- American Society of Clinical Oncology 2008 Gastrointestinal Cancers Symposium, abst. 300
- Year
- 2008
- Research Committee(s)
- Gastrointestinal
- Study Number(s)
- SWOG-9304 (INT-0144)
Pharmacogenetic analysis of stage II/III rectal cancer patients treated with 5-fluorouracil and pelvic radiation in a phase III intergroup trial (INT-0144, SWOG 9304)
- Journal / Conference
- American Society of Clinical Oncology 2008 Gastrointestinal Cancers Symposium, abst. 309, p. 223
- Year
- 2008
- Research Committee(s)
- Gastrointestinal
- Study Number(s)
- SWOG-9304 (INT-0144)
Polymorphisms in folate-metabolizing enzymes and response to 5-fluorouracil among stage II or III rectal cancer patients (SWOG 9304)
- Journal / Conference
- American Urological Assn Annual Meeting, "late breaking" presentation
- Year
- 2008
- Research Committee(s)
- Genitourinary
- Study Number(s)
- SWOG-8794
Adjuvant radiotherapy for pT3 for prostate cancer: results of a randomized, prospective clinical trial, 2008 update
- Journal / Conference
- Journal of Thoracic Oncology 3(11) supp. 4:S266, abst. #9
- Year
- 2008
- Research Committee(s)
- Lung
- Study Number(s)
- S0536